The COVID Advisor

Ivermectin and hydroxychloroquine prescriptions “soared far above” levels before the COVID-19 pandemic, according to a 2025 study. Researchers from the University of California - Los Angeles (UCLA) and other institutions said that nearly 3 million ivermectin and hydroxychloroquine prescriptions were issued during the pandemic, totaling some $272 million, according to a news release issued on Feb. 20. The dispensing of ivermectin “from US pharmacies was nearly 1,000 percent higher than prepandemic rates,” the study said. Early Treatment League Table: Hydroxychloroquine (66%) vs Ivermectin (61%) Usage of the two drugs was three times higher in people aged 65 and older, compared with people aged 18 to 64, according to the study published in the Health Affairs journal . Patients aged 65 and older represented 25 percent of adults in the study but constituted more than 59 percent of COVID-19-linked ivermectin usage and 68 percent of COVID-19-related hydroxychloroquine use, it found. Hydroxy...

As of March 2025, there are  more than 4,000 studies  published related to the treatment and prevention of COVID-19. If you are still confused about the recommendations made by different professional groups for the COVID-19 pandemic, you've come to the right place. The number of options for the treatment of COVID-19 has increased drastically in recent months, thus making it complicated when it comes to choosing the right combination. In general, there are 3 broad categories of medical interventions: Prevention or Prophylaxis e.g. vaccine Early out-patient treatment Hospital treatment The various treatments available for different conditions often involve the use of complex technologies and specialized terminology, which can be overwhelming and confusing for consumers. To achieve the best possible outcome, multiple treatments and comprehensive strategies are typically used in combination. Therefore, it's important to work closely with your healthcare provider to understand the ...

Early treatment is critical and the most important factor in managing this disease. COVID-19 is a clinical diagnosis; a confirmed antigen or PCR test is not required. Treatment should be initiated immediately after the onset of flu-like symptoms. The multiple therapies and drugs in this protocol have different mechanisms of action and work synergistically during various phases of the disease. About I-CARE Protocol The information in this document is our recommended approach to COVID-19 based on the best (and most recent) literature. It is provided as guidance to healthcare providers worldwide on the early treatment of COVID-19. Patients should always consult with their provider before starting any medical treatment. New medications may be added and/or changes made to doses of existing medications as further evidence emerges. Please be sure you are using the latest version of this protocol. Warning (anesthesia and surgery): Please notify your anesthesia team if you are using the followi...